Make an appointment by phone
Make an appointment with MyChart
Book with MyChart
Hours of Operation: Monday-Friday - 8:00 AM - 5:00 PM
Call for assistance with the referral process
The Pulmonology Department comprehensive diagnosis, treatment, education, and rehabilitation services for a full range of pulmonary diseases and allergy conditions. The practice has an award-winning clinical program in asthma and expertise in fibrotic lung disease, bronchiectasis, pulmonary hypertension, sarcoidosis, and tuberculosis. Several of the physicians have been recognized for their excellence in patient care by the Consumers' Guide to Top Doctors. All of the physicians are board-certified in pulmonary medicine and some have additional certification in allergy and immunology and critical care medicine.
Refer a Patient - 617.638.5795, #1111. Prior to your patient's first visit, please fax their medical records and a letter explaining the reason for the referral to 617.638.7486.
Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).
Treatments & Services
The Interventional Bronchoscopy program is dedicated to the care of patients with complex airway disease including obstructing cancers, broncholiths, relapsing polychondritis, tracheoesophageal fistulae, tracheobronchial and laryngeal amyloidosis, papillomatosis, tracheal stenoses, and tracheomalacia.
Pulmonary and Exercise Physiology
The Pulmonary Physiology service provides comprehensive, state-of-the-art assessment of respiratory mechanics and function. The goal is to assist the clinician in the diagnosis and prognosis of all forms of pulmonary-related diseases and to assist the clinical investigator in the pursuit of understanding and defining pulmonary disease through research.
Amyloidosis,, pleural disease, pulmonary fibrosis
Lung Cancer Diagnostics
General pulmonary medicine
Human lung development, cystic fibrosis
Tobacco dependence; Sleep-disordered breathing
Pulmonary hypertension, pulmonary complications of sickle cell disease, pulmonary embolism, chronic dyspnea
Asthma, allergies, critical care medicine, and eosinophilic disorders
Asthma, COPD, bronchiectasis, critical care
Diseases of the nose, sinuses, and anterior skull base, endoscopic procedures
Lung cancer, lung nodule evaluation
BOSTON – New research results show that a new form of gene editing is efficient in correcting a mutation in patient cells with the monogenic disease Alpha-1 antitrypsin deficiency (AATD), a common…
BOSTON – Alpha-1 antitrypsin deficiency (AATD) is an important and under-recognized genetic cause of liver disease. The most common mutation associated with liver…
The physicians and staff of the Pulmonary, Allergy, Sleep & Critical Care Medicine section at Boston Medical Center are also affiliated with the Boston University Chobanian & Avedisian School of Medicine. For more information on research studies, please visit the Pulmonary, Allergy, Sleep & Critical Care Medicine Boston University Chobanian & Avedisian School of Medicine Website.
Residency and Fellowship Information
The Pulmonary, Allergy, Sleep & Critical Care Medicine section at Boston Medical Center is affiliated with the Boston University Chobanian & Avedisian School of Medicine. To learn about the fellowship programs, please visit the Pulmonary, Allergy, Sleep & Critical Care Medicine section of the Boston University Chobanian & Avedisian School of Medicine website.
Latest from HealthCity
Progress toward improving outcomes for adults with sickle cell disease hinges on more qualified, trained physicians and investment in research.
Comprehensive, multidisciplinary services that provide whole-person care can be difficult to find. Experts are changing that.
New technologies can produce billions of cells, creating research opportunities that promise to advance our understanding of serious lung diseases.